VisionPLUS
VisionPLUS, licence 80144698: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Natra Labs Ltd.
- NPN or DIN-HM
- 80144698
- Status
- Active licence
- Licence date
- 9 October 2025
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 18 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'R)-bêta,bêta-Carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 1.25 mg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 26.8 mg AT | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 40.0 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 12.5 Microgrammes | Not calculated |
| Vitamine D Source : Cholécalciférol | 500.0 UI | 25 µg |
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 10.0 mg | Not calculated |
| Zinc Source : Sulfate de zinc | 9.0 mg | 18,000 µg |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 6000 mg Potency : 36.0 % Anthocyanins | 60.0 mg | Not calculated |
| Cuivre Source : Sulfate de cuivre (II) | 0.9 mg | 1,800 µg |
| Vitamine A | 675.0 Microgrammes | Not calculated |
| Vitamine A | 2250.0 UI | Not calculated |
Non-medicinal ingredients
Huile de pépin de raisin, Lécithine, Cire d'abeille jaune, Gélatine, Fruit séché de Lycium barbarum, Glycérine, Eau purifiée, Rocou
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in connective tissue formation. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of night vision. Helps to form red blood cells. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal iron transport in the body. Helps to maintain/support normal vision/eyesight/eye health/(and) night vision. Helps to maintain/support the body's ability to metabolize nutrients. Helps to produce and repair connective tissue. Helps to provide eyesight/skin/mucous membranes/(and) immune function support. Maintains/supports normal vision/eyesight/eye health/(and) night vision. Source of/Provides (an) antioxidant(s) for the maintenance of good health. Source of/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides an antioxidant that protects the fat in body tissues from oxidation. Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Source of/Provides (an) antioxidant(s) (for the maintenance of good health). Source of/Provides (an) antioxidant(s) for the maintenance of eye health. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of antioxidants/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144698
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.